Gene Therapy Market - Top Companies and Manufacturers

Companies Dominating the Gene Therapy Landscape

The introduction of new medicines, technologically sophisticated product launches, regulatory approvals, acquisitions, and joint ventures with other businesses are the activities of major players in the global market. These tactics are probably going to encourage the worldwide market's expansion.

Novartis AG
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

Biogen Inc.
Gilead Sciences, Inc.
Bristol–Myers Squibb
Alnylam Pharmaceuticals, Inc.
Sarepta Therapeutics, Inc.
Orchard Therapeutics Limited
Celgene Corporation
Spark Therapeutics, Inc.
Sibino GeneTech Co., Ltd.

Browse Key Market Insights with Data Illustration:

Gene Therapy Market Size & Share, Growth Forecasts 2037

In the News

Novartis presented new research demonstrating the transformational and long–term benefits of Zolgensma, a one–time gene therapy for the treatment of spinal muscular atrophy (SMA). The most recent findings from two Long–Term Follow–Up (LTFU) trials, LT–001 and LT–002, reveal that Zolgensma continues to be efficacious and durable across a wide variety of patient demographics, with a positive overall benefit–risk profile.
Biogen Inc. announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending a marketing authorization under exceptional circumstances for QALSODY® for the treatment of adults with amyotrophic lateral sclerosis (ALS) caused by a mutation in the superoxide dismutase 1 gene.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of gene therapy is estimated at USD 12.48 billion.

The gene therapy market size was valued at USD 10.71 billion in 2024 and is likely to cross USD 122.27 billion by 2037, registering more than 20.6% CAGR during the forecast period i.e., between 2025-2037. The market is expanding due to rise in cancer patients and deaths associated with the disease highlighting the need for effective therapeutic alternatives.

North America industry is poised to hold largest revenue share of 37% by 2037, influenced by presence of extremely sophisticated infrastructure in hospitals in the region.

The major players in the market are Novartis AG, Biogen Inc., Gilead Sciences, Inc., BristolÃ¢â‚¬â€œMyers Squibb, Alnylam Pharmaceuticals, Inc., Sarepta Therapeutics, Inc., Orchard Therapeutics Limited, Celgene Corporation, Spark Therapeutics, Inc., Sibino GeneTech Co., Ltd., and others.

Gene Therapy Market - Top Companies and Manufacturers

Companies Dominating the Gene Therapy Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What is the size of the gene therapy market?

Why is the gene therapy sector gaining traction in near future?

Which region accounted for the largest gene therapy industry share?

Who are the major gene therapy players?